Evidence map›Paper›PMID 37673680›Full record

ReviewJournal of industrial microbiology & biotechnology2023

Biosynthesis, enzymology, and future of eunicellane diterpenoids.

Zining Li, Jeffrey D Rudolf

Open access · goldAbstract readReview
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Computation-guided scaffold exploration of 2Beilstein journal of organic chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zining LiDepartment of Chemistry, University of Florida, Gainesville, FL 32611-7011, USA.ORCID 0000-0002-6921-8417
Jeffrey D RudolfDepartment of Chemistry, University of Florida, Gainesville, FL 32611-7011, USA.ORCID 0000-0003-2718-9651
University of Florida · US

Funding

Discovery and Biosynthesis of Bacterial TerpenoidsR35GM142574 · NIGMS · UNIVERSITY OF FLORIDA · PI Jeffrey Daniel Rudolf · 2021 to 2026
$2.4M
NIGMS NIH HHS R35 GM142574NIH HHS R35 GM142574
6 · The paper itself

Abstract

Eunicellane diterpenoids are a remarkable family of terpene natural products and have been of high interest for over five decades. Widely distributed in soft corals and rare in plants, eunicellanes were also recently identified in actinobacteria. These terpenoids have foundational 6/10-bicyclic frameworks that are frequently oxidized into structures containing transannular ether bridges. Interest in their unique structures and promising biological activities, such as the paclitaxel-like activities of eleutherobin and the sarcodictyins, has led to advancements in natural product isolation, total synthesis, medicinal chemistry, and drug lead development. Until recently, however, there was little known about the biosynthesis and enzymology of these natural products, but several recent studies in both bacteria and coral have opened up the field. This review summarizes recent advancements in the biosynthesis and enzymology of eunicellane diterpenoids and highlights future research prospects in the field. ONE-SENTENCE SUMMARY: A summary of recent advancements in the biosynthesis and enzymology of eunicellane diterpenoids, a structurally unique and biologically active family of natural products found in coral, plants, and bacteria.

Indexed as

Biological ProductsDiterpenesBacteriaPaclitaxelBiological ProductsDiterpenesPaclitaxelBiosynthesisDiterpenoidsEunicellanesGenome miningTerpene synthase

Identifiers

PMID37673680
PMCPMC10548852
OpenAlexW4386467685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.